FDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQ
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
75F40126R00020
NAICS
541690 - Other Scientific and Technical Consulting Services
Classification Code
R499
Additional Details
The U.S. Food and Drug Administration (FDA), under the Department of Health and Human Services, has released Solicitation No. 75F40126R00020, titled "Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQ." This procurement seeks to establish a single-award Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract to provide comprehensive support services in occupational safety, industrial hygiene, information systems, and training across FDA headquarters and its nationwide network of laboratory and field facilities. The contract is managed by the FDA Office of Acquisition and Grant Services, with primary contacts Sheneil Green ([email protected], 301-796-0675) and L. Maria Finan ([email protected], 1-240-402-5712).
**Purpose and Scope**
The primary objective of this procurement is to secure enterprise-wide support for the FDA’s occupational safety and health programs, laboratory quality initiatives, industrial hygiene activities, information systems, and training development. The contract is designed to ensure the FDA maintains high standards of safety, compliance, and operational efficiency in its diverse and complex environments, including high-containment laboratories and field operations.
**Key Requirements and Task Areas**
The Performance Work Statement (PWS) outlines several core task areas that the contractor must be prepared to address:
- **Program and Order Management:** Overseeing all aspects of contract and task order execution, ensuring timely and compliant delivery of services.
- **Transition Services:** Facilitating a seamless transition at contract start and, if necessary, at contract conclusion.
- **Occupational Safety, Policy, and Laboratory Quality Support:** Providing expertise in safety program management, policy development, and laboratory quality assurance.
- **Primary Barrier Equipment Maintenance and Certification:** Maintaining and certifying critical laboratory containment equipment.
- **Industrial Hygiene Support Services:** Delivering industrial hygiene assessments, monitoring, and hazard mitigation.
- **Information and Data Systems Support:** Supporting the development, maintenance, and integration of information systems relevant to safety and industrial hygiene.
- **Training Development and Management:** Designing and delivering training programs to ensure FDA personnel are equipped with up-to-date knowledge and skills.
**Initial Task Order**
Upon award, the first task order will be issued concurrently as a firm-fixed-price requirement, focusing on "CBER BSL-3 Annual Re-Verification and Decontamination Services." This includes:
- BSL-3 laboratory re-verification and certification
- Primary barrier equipment certification validation
- HVAC airflow and pressure differential testing
- Vaporized Hydrogen Peroxide (VHP) decontamination
- Biosafety compliance assessments
- Deficiency identification and corrective action analysis
- Preparation of verification reports and certification documentation
**Contract Structure and Value**
The IDIQ contract will have a five-year ordering period from the date of award, with a total ceiling value of $14,500,000. The contract allows for a variety of task order types, including Firm-Fixed-Price (FFP), Time-and-Materials (T&M), Labor-Hour (LH), or hybrid arrangements, providing flexibility to address the FDA’s evolving needs. The guaranteed minimum is satisfied through the initial task order.
**Competition and Evaluation**
This procurement is being conducted on a full and open competition basis, in accordance with FAR Parts 12, 15, and 16.5. There are no set-aside restrictions; all qualified offerors are encouraged to participate. Proposals will be evaluated using a Best-Value Tradeoff process, with the following factors (in descending order of importance):
1. Corporate Experience
2. Technical Approach
3. Management Approach
4. Past Performance
5. Price
6. Subcontracting Plan (required for other-than-small businesses)
Non-price factors, when combined, are significantly more important than price.
**Proposal Submission and Instructions**
Offerors must submit proposals electronically, following the instructions in Section L of the solicitation. Hard-copy submissions will not be accepted. Required proposal volumes include:
- Volume 0 – Administrative
- Volume I – Technical Proposal
- Volume II – Price Proposal
- Volume III – Subcontracting Plan (if applicable)
Offerors are responsible for monitoring SAM.gov for all solicitation updates, amendments, and responses to questions. All questions must be submitted using the provided template (Attachment R5) by June 16, 2026. The proposal due date is October 7, 2026, at 16:07.
**Contracting Entity and Location**
The place of performance is primarily Silver Spring, Maryland, but services may be required at FDA facilities nationwide. The procurement is classified under NAICS Code 541690 (Other Scientific and Technical Consulting Services) and Product Service Code R499.
**Additional Considerations**
Offerors must be registered and maintain active status in the System for Award Management (SAM) throughout the contract period. The solicitation and all related documents, including amendments and attachments, are available on SAM.gov (Opportunity ID: e411ae9fe39d4898a29d336e7a0f807e).
**Summary for Contractors**
This opportunity is well-suited for firms with demonstrated expertise in occupational safety, industrial hygiene, laboratory quality assurance, and related information systems and training. The contract’s broad scope, significant ceiling, and nationwide reach require robust program management capabilities and the ability to deliver specialized technical services in high-containment laboratory environments. The FDA’s emphasis on best value, technical excellence, and past performance underscores the need for offerors to present comprehensive, well-documented proposals that address all aspects of the PWS and evaluation criteria.
For further information or to access the full solicitation package, visit the SAM.gov opportunity page or contact the designated FDA contracting officials.
Documents21